UPC APP 47172/2024

Aug 14, 2024·EP3666797: ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Case details: Status
Written Phase
Action
Generic
Category
Other Procedural
Parties: Claimants
Dehns
Reps: John Somerton
Respondents
Sanofi-Aventis Deutschland GmbH
Amgen Inc.
Reps: Daniel Wise; Koen Bijvank
Division: Munich CD
Judges: Ulrike Voß
Andras Kupecz
Casper Struve
Technology: Biotechnology
Language: English
First decided: Oct 22, 2024

Documents

Document title	Date	Public
Procedural Order App_47172/2024	2024-10-23	Not public
Headnote-and-Keywords	2024-10-22	Not public
Outcome of the Order	2024-10-22	Not public
262.1(b) order	2024-10-22	Not public
262.1(b) order	2024-10-22	Public
Template-Order	2024-10-22	Not public
opportunity to comment for applicant	2024-09-10	Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed	2024-08-29	Not public
US Delaware District Court Memorandum Order	2024-08-29	Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed	2024-08-29	Not public
US Delaware District Court Memorandum Order	2024-08-29	Not public
2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed	2024-08-29	Not public
US Delaware District Court Memorandum Order	2024-08-29	Not public
Reply to RoP 262.1(b)	2024-08-22	Not public
Opportunity to comment	2024-08-15	Not public
Access Request under RoP262.1(b)	2024-08-14	Not public